SCHEMBL7473919

SCHEMBL7473919

O=C(O)Nc1nc(-c2ccc(NC(=O)CBr)cc2)cs1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.55
▸ NPC1 O15118 4/20 0.55
▸ SMN1; SMN2 Q16637 3/20 0.55
▸ MAPT P10636 5/20 0.55
▸ GAA P10253 4/20 0.55
▸ ADORA3 P0DMS8 1/20 0.54
▸ KMT2A Q03164 7/20 0.54
▸ MEN1 O00255 6/20 0.54
▸ ALDH1A1 P00352 4/20 0.54
▸ LMNA P02545 4/20 0.54
▸ MAPK1 P28482 2/20 0.54
▸ HTT P42858 1/20 0.54
▸ GFER P55789 3/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ ELOVL1 Q9BW60 1/20 0.52
▸ ROCK1 Q13464 1/20 0.51
▸ CASP3 P42574 1/20 0.51
▸ SENP7 Q9BQF6 1/20 0.51
▸ PKM P14618 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2452315 0.83 ELOVL1 (0.72) RAB9ANPC1SMN1; SMN2MAPTADORA3
SCHEMBL4420194 0.83 HDAC1 (0.65) RAB9ANPC1SMN1; SMN2MAPTGAA
SCHEMBL4408570 0.82 GAA (0.61) RAB9ANPC1SMN1; SMN2MAPTGAA
SCHEMBL7473414 0.82 HDAC3 (0.52) RAB9ANPC1SMN1; SMN2MAPTGAA
SCHEMBL4416778 0.82 RAB9A (0.63) RAB9ANPC1SMN1; SMN2MAPTKMT2A
SCHEMBL21586296 0.81 KMT2A (0.74) RAB9ASMN1; SMN2MAPTGAAKMT2A
SCHEMBL480758 0.81 MAPT (0.71) RAB9ANPC1SMN1; SMN2MAPTGAA
SCHEMBL21586350 0.80 ROCK1 (0.59) RAB9ANPC1SMN1; SMN2MAPTGAA
SCHEMBL4410636 0.80 MAPT (0.70) RAB9ANPC1SMN1; SMN2MAPTGAA
SCHEMBL3823589 0.78 MAPT (0.72) RAB9ANPC1SMN1; SMN2MAPTADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0871619-B1 PHENYL THIAZOLE DERIVATIVES WITH ANTI HERPES VIRUS PROPERTIES BOEHRINGER INGELHEIM PHARMA (US) 2002-11-06 — — EP disclosed
US-6458959-B1 VIRICIDES AND ENZYME INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2002-10-01 — — US disclosed
US-6348477-B1 SUBSTITUTED PHENYL THIAZOLE DERIVATIVES AS VIRICIDES BOEHRINGER INGELHEIM(CANADA) LTD. (CA) 2002-02-19 — — US disclosed
US-6288091-B1 COMPOUNDS SUCH AS 2,2,2-TRICHLOROETHYL N-(4-(2-AMINO-4-THIAZOLYL)-PHENYL)CARBAMATE THAT INHIBIT THE HERPES HELCASE-PRIMASE ENZYME COMPLEX BOEHRINGER INGELHEIM LTD. (CA) 2001-09-11 — — US disclosed
US-6057451-A AMINOTHIAZOLE DERIVATIVES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2000-05-02 — — US disclosed
EP-0871619-A1 PHENYL THIAZOLE DERIVATIVES WITH ANTI HERPES VIRUS PROPERTIES BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1998-10-21 — — EP disclosed
WO-1997024343-A1 PHENYL THIAZOLE DERIVATIVES WITH ANTI HERPES VIRUS PROPERTIES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1997-07-10 — — WO disclosed
Send feedback